**Core Concept:** Choriocarcinoma is a malignant tumor derived from trophoblastic cells, while invasive mole (chorioadenoma destruens) is a benign tumor due to a monozygotic twin separation. These two entities are clinically similar, but choriocarcinoma is associated with elevated serum human chorionic gonadotropin (hCG) levels, while invasive mole has normal or slightly elevated hCG levels.

**Why the Correct Answer is Right:**

Choriocarcinoma is differentiated from invasive mole (chorioadenoma destruens) based on several factors:

1. **Pathogenesis:** Choriocarcinoma develops from malignant trophoblastic cells, while invasive mole is a result of monozygotic twin separation. This distinction is important because choriocarcinoma is a malignant tumor with the potential for distant spread and poor prognosis, while invasive mole is a benign tumor with a generally favorable prognosis and less aggressive behavior.
2. **Clinical presentation:** Choriocarcinoma typically presents with symptoms related to hormone production and secretion, such as abdominal pain, vaginal bleeding, and elevated serum hCG levels. In contrast, invasive mole often presents with asymptomatic or mild symptoms, with normal or slightly elevated serum hCG levels.
3. **Serum hCG levels:** As mentioned above, choriocarcinoma is associated with elevated serum hCG levels, while invasive mole is usually characterized by normal or slightly elevated hCG levels.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because invasive mole (chorioadenoma destruens) typically presents with normal or slightly elevated serum hCG levels, which is different from the elevated hCG levels seen in choriocarcinoma.

B. This option is incorrect because the presence of elevated serum hCG levels in choriocarcinoma is not solely based on the tumor's invasiveness. Invasive mole can also have elevated hCG levels due to its trophoblastic nature, making this distinction unreliable.

C. This option is incorrect because the invasion of the uterine wall is not the primary factor differentiating choriocarcinoma from invasive mole. Instead, it is the serum hCG levels that help differentiate between these two entities.

D. This option is incorrect because the distinction between choriocarcinoma and invasive mole is not solely based on the absence of invasion. Although both tumors can be associated with elevated serum hCG levels, invasive mole has a better prognosis because it is generally a benign lesion, while choriocarcinoma is malignant and has the potential for distant spread.

**Clinical Pearl:** In cases of elevated serum hCG levels, consider the possibility of choriocarcinoma, as it poses a higher risk for distant spread compared to invasive mole. However, evaluating the patient's clinical presentation, serum hCG levels, and gestational history is crucial for accurate diagnosis and appropriate management.